Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis
H. Bachelez(Délégation Paris 7), Siew Eng Choon(Monash University Malaysia), Slaheddine Marrakchi(Hopital Universitaire Hedi Chaker), A. David Burden(University of Glasgow), Tsen‐Fang Tsai(National Taiwan University), Akimichi Morita(Nagoya City University), H. Turki(Hopital Universitaire Hedi Chaker), David B. Hall(Boehringer Ingelheim (United States)), Michael Shear(Boehringer Ingelheim (Germany)), Patrick Baum(Boehringer Ingelheim (Germany)), Steven J. Padula(Boehringer Ingelheim (Germany)), Christian Thoma(Boehringer Ingelheim (Germany))
Cited by 287Open Access
Abstract
Interleukin-36 Blockade in Pustular Psoriasis Seven patients with pustular psoriasis, three with mutations in IL36RN, were treated with a monoclonal antibody against interleukin-36 receptor and had...
Related Papers
No related papers found
Powered by citation graph analysis